Skip to content
TrialScanner

NCT06018558

Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy

Phase 1/Phase 2Active, not recruitingOCGNLead

Registry record

Lead sponsor
Ocugen
Conditions
Geographic Atrophy
Primary completion
Feb 3, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06018558 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.